Examiner: CORNELIUS, CLAIRE ADRIENNE

Tech Center 1600 • Art Units: 1600 1632 1671 1672

This examiner grants 100% of resolved cases

Performance Statistics

100.0%

Allow Rate

+40.0% vs TC avg

Total Applications

+0.0%

Interview Lift

1141

Avg Prosecution Days

Based on 3 resolved cases, 2023–2026

16.3%

§101 Eligibility

11.2%

§102 Novelty

30.6%

§103 Obviousness

36.7%

§112 Clarity

App #	Title	Status	Assignee
18654961	VIRAL ANTIGEN DISPLAY COMPOSITIONS AND METHODS	Non-Final OA	REGENTS OF THE UNIVERSITY OF MINNESOTA
18277873	NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME	Non-Final OA	CJ CheilJedang Corporation
18262073	Therapeutic Viral Vaccine	Final Rejection	GlaxoSmithKline Biologicals SA

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.